A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a robust trade exists on messaging services, where groups with numerous of participants share comparison images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to users injecting substances of unknown origin.
Some experts said the demand for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.
Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, risking fines, prosecution or imprisonment.
Service Response and Content Elimination
According to TikTok, the service has removed violative material and prohibited associated keywords and query recommendations. The organization said it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.
Online Marketplace Activities
Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, populated with images of slimming results, glowing testimonials and detailed guides for mixing or administering at residence.
After moments of joining one community, a seller posted contact information, where most transactions occur. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, medical conditions or past usage.
Item Information and Pricing
Inside these groups, messages show dark colored packages with postal service labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for Telegram stated it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting materials they cannot confirm. Although the research behind this drug is valid, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has already seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially serious health risks”.
